Obserwuj
Kay Tetzlaff
Kay Tetzlaff
University of Tuebingen, Dept. of Sports Medicine
Zweryfikowany adres z klinikum.uni-tuebingen.de - Strona główna
Tytuł
Cytowane przez
Cytowane przez
Rok
Nintedanib in progressive fibrosing interstitial lung diseases
KR Flaherty, AU Wells, V Cottin, A Devaraj, SLF Walsh, Y Inoue, ...
New England Journal of Medicine 381 (18), 1718-1727, 2019
16792019
Nintedanib for systemic sclerosis–associated interstitial lung disease
O Distler, KB Highland, M Gahlemann, A Azuma, A Fischer, MD Mayes, ...
New England Journal of Medicine 380 (26), 2518-2528, 2019
12832019
Withdrawal of inhaled glucocorticoids and exacerbations of COPD
H Magnussen, B Disse, R Rodriguez-Roisin, A Kirsten, H Watz, K Tetzlaff, ...
New England Journal of Medicine 371 (14), 1285-1294, 2014
7802014
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial
H Watz, K Tetzlaff, EFM Wouters, A Kirsten, H Magnussen, ...
The lancet Respiratory medicine 4 (5), 390-398, 2016
5012016
Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4)
R Buhl, F Maltais, R Abrahams, L Bjermer, E Derom, G Ferguson, ...
European Respiratory Journal 45 (4), 969-979, 2015
4382015
The natural history of progressive fibrosing interstitial lung diseases
KK Brown, FJ Martinez, SLF Walsh, VJ Thannickal, A Prasse, ...
European Respiratory Journal 55 (6), 2020
1892020
Trial of spesolimab for generalized pustular psoriasis
H Bachelez, SE Choon, S Marrakchi, AD Burden, TF Tsai, A Morita, ...
New England Journal of Medicine 385 (26), 2431-2440, 2021
1772021
The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease
KM Beeh, J Westerman, AM Kirsten, J Hébert, L Grönke, A Hamilton, ...
Pulmonary pharmacology & therapeutics 32, 53-59, 2015
1552015
Pulmonary Wegener's granulomatosis: correlation between high-resolution CT findings and clinical scoring of disease activity
M Reuter, A Schnabel, F Wesner, K Tetzlaff, Y Risheng, WL Gross, ...
Chest 114 (2), 500-506, 1998
1421998
Eosinophilia, frequent exacerbations, and steroid response in chronic obstructive pulmonary disease
PMA Calverley, K Tetzlaff, C Vogelmeier, LM Fabbri, H Magnussen, ...
American journal of respiratory and critical care medicine 196 (9), 1219-1221, 2017
1392017
Risk factors for pulmonary barotrauma in divers
K Tetzloff, E Bettinghausen, M Renter, M Heller, B Leplow
Chest 112 (3), 654-659, 1997
1391997
Plasma fibrinogen as a biomarker for mortality and hospitalized exacerbations in people with COPD
DM Mannino, R Tal-Singer, DA Lomas, J Vestbo, G Barr, K Tetzlaff, ...
Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 2 (1), 23, 2015
1242015
The 6-minute-walk distance test as a chronic obstructive pulmonary disease stratification tool. Insights from the COPD biomarker qualification consortium
B Celli, K Tetzlaff, G Criner, MI Polkey, F Sciurba, R Casaburi, ...
American journal of respiratory and critical care medicine 194 (12), 1483-1493, 2016
1152016
MR imaging of the central nervous system in diving-related decompression illness
M Reuter, K Tetzlaff, A Hutzelmann, G Fritsch, JC Steffens, ...
Acta Radiologica 38 (6), 940-944, 1997
981997
Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease
PG Woodruff, M Wolff, JM Hohlfeld, N Krug, MT Dransfield, ER Sutherland, ...
American journal of respiratory and critical care medicine 181 (5), 438-445, 2010
932010
Development and validation of a cough and sputum assessment questionnaire
B Crawford, B Monz, J Hohlfeld, N Roche, B Rubin, H Magnussen, ...
Respiratory medicine 102 (11), 1545-1555, 2008
872008
Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment
IP Hall, AV Fowler, A Gupta, K Tetzlaff, MC Nivens, M Sarno, HA Finnigan, ...
Pulmonary pharmacology & therapeutics 32, 37-44, 2015
822015
Arteriovenous bubbles following cold water sport dives: relation to right-to-left shunting
T Gerriets, K Tetzlaff, T Liceni, C Schafer, B Rosengarten, G Kopiske, ...
Neurology 55 (11), 1741-1743, 2000
772000
Breathing at depth: physiologic and clinical aspects of diving while breathing compressed gas
K Tetzlaff, E Thorsen
Clinics in chest medicine 26 (3), 355-380, 2005
672005
Expiratory flow limitation in compressed air divers and oxygen divers
K Tetzlaff, L Friege, M Reuter, J Haber, T Mutzbauer, B Neubauer
European Respiratory Journal 12 (4), 895-899, 1998
651998
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20